Loading…
biote Corp. is projected to rise to $3.36 by 2027, a +44% move from its current price of $2.33. BTMD is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 12 | $2.23 | $2.33 | $2.43 | -0.05% |
| Jul 13 | $2.19 | $2.33 | $2.48 | -0.10% |
| Jul 14 | $2.16 | $2.33 | $2.51 | -0.15% |
| Jul 15 | $2.13 | $2.33 | $2.54 | -0.20% |
| Jul 16 | $2.11 | $2.32 | $2.56 | -0.25% |
| Jul 17 | $2.09 | $2.32 | $2.58 | -0.31% |
| Jul 18 | $2.07 | $2.32 | $2.61 | -0.36% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $2.07 | $2.32 | $2.61 | -0.36% |
| Week 2 | $1.97 | $2.31 | $2.72 | -0.71% |
| Week 3 | $1.89 | $2.31 | $2.82 | -1.06% |
| Week 4 | $1.82 | $2.30 | $2.89 | -1.42% |
| Week 5 | $1.77 | $2.29 | $2.96 | -1.77% |
| Week 6 | $1.72 | $2.28 | $3.03 | -2.12% |
| Week 7 | $1.67 | $2.27 | $3.08 | -2.47% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
biote Corp. operates in the Healthcare sector, focusing on practice-building in the hormone optimization space. It trains physicians and nurse practitioners in hormone optimization using bioidentical hormone replacement pellet therapy in men and women experiencing hormonal imbalance.
The Biote Method is a comprehensive end-to-end practice-building platform that provides Biote-certified practitioners with the components developed for practitioners in the hormone optimization space comprising Biote Method education, training, and certification; practice management software that allows Biote-certified practitioners to order, track, and manage hormone optimization product inventory and meet other administrative requirements; inventory management software to facilitate ordering and inventory control; and information regarding available hormone replacement therapy products, as well as digital and point-of-care marketing support.
Biote Corp. trades under the BTMD symbol. The current price is $2.33 and the market capitalization stands at $82.84M, with a global rank of 4282. The stock sits in a micro-cap space and is subject to notable volatility in trading.
The price outlook from the supplied forecast shows an upward trajectory over time. The 2026 average price is $2.33, rising to $3.36 in 2027, and $4.19 by 2030. Longer horizon projections show further upside to $7.10 in 2035, $8.27 in 2040, and $16.28 by 2050, with corresponding ROIs of 44%, 79.9%, 254.9%, and 598.8% and bullish sentiment in those years.
A major floor 44.2% below — a decisive break under it would weaken the trend.
The nearest floor, 28.3% below — buyers have tended to step in here.
The nearest ceiling, 5.6% above — a clean break opens room to run.
A major ceiling 26.3% above — clearing it would confirm fresh momentum.
Key BTMD support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of BTMD market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $2.28 | Buy | $2.25 | Buy |
| MA 10 | $2.09 | Buy | $2.19 | Buy |
| MA 20 | $2.16 | Buy | $2.16 | Buy |
| MA 50 | $2.14 | Buy | $2.12 | Buy |
| MA 100 | $1.97 | Buy | $2.14 | Buy |
| MA 200 | $2.29 | Buy | $2.43 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 58.33 | Neutral |
| Stoch RSI (14) | 100.00 | Sell |
| CCI (20) | 71.07 | Neutral |
| Williams %R (14) | 0.00 | Info |
| MACD (12,26,9) | 0.03 | Buy |
| ROC (12) | 8.37 | Buy |
| Bollinger %B (20,2) | 0.71 | Neutral |
| Stochastic %K (14) | 100.00 | Sell |
| TRIX (15) | -0.04 | Sell |
| Awesome (5,34) | 0.13 | Buy |
| Ultimate (7,14,28) | 76.85 | Sell |
| Momentum (10) | 0.37 | Buy |
| Aroon Osc (25) | -40.00 | Sell |
| Hull MA (9) | 2.37 | Sell |
| ADX (14) | 14.77 | Neutral |
| ATR (14) | 0.08 | Info |
The 30-day technical picture is bullish. RSI14 is 60, indicating modest positive momentum. The short-term moving averages are $2.14 for SMA50 and $2.29 for SMA200, providing near-term support and price guidance. Key levels to watch are support at $1.67 and resistance at $2.46, with the 30-day trading range between $1.75 and $3.11.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $1.30 | $2.33 | $2.94 | 0% | Neutral | |
| $2.52 | $3.36 | $4.80 | +44% | Bullish | |
| $2.53 | $3.53 | $5.33 | +51% | Bullish | |
| $2.58 | $3.74 | $5.90 | +61% | Bullish | |
| $2.78 | $4.19 | $6.83 | +80% | Bullish | |
| $2.44 | $3.79 | $6.37 | +63% | Bullish | |
| $2.56 | $4.11 | $7.10 | +77% | Bullish | |
| $2.87 | $4.75 | $8.39 | +104% | Bullish | |
| $3.35 | $5.70 | $10.30 | +145% | Bullish | |
| $4.05 | $7.10 | $13.09 | +205% | Bullish | |
| $4.13 | $8.27 | $16.59 | +255% | Bullish | |
| $7.33 | $16.28 | $36.79 | +599% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $1.30 | $2.33 | $2.69 | +0.00% |
| August 2026 | $1.78 | $2.14 | $2.66 | -8.11% |
| September 2026 | $1.83 | $2.22 | $2.81 | +3.88% |
| October 2026 | $1.81 | $2.21 | $2.84 | -0.48% |
| November 2026 | $1.72 | $2.13 | $2.77 | -3.72% |
| December 2026 | $1.80 | $2.24 | $2.94 | +5.21% |
Click any year to see its month-by-month BTMD forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect BTMD to range from $1.30 to $2.94 through 2026. The $2.33 average target implies a 0% move from current prices. Price action looks broadly range-bound.
The BTMD price prediction for 2027 points to an average of $3.36 (low $2.52, high $4.80) — a potential gain of +44% on today's $2.33. Buyers look set to stay in control over this stretch.
In 2028, BTMD is projected to trade between $2.53 and $5.33, averaging $3.53 — a potential gain of +51% from today's $2.33. That is up +5% on the projected 2027 average. Momentum favours further upside here.
biote Corp.'s 2029 outlook centres on $3.74, within a $2.58 to $5.90 range. That is up +6% on the projected 2028 average. That marks a +61% change versus current levels. Buyers look set to stay in control over this stretch.
By 2030, BTMD could reach as high as $6.83, with a base case around $4.19 and support toward $2.78 — roughly +80% from $2.33. Momentum favours further upside here.
Expect BTMD to range from $2.44 to $6.37 through 2031. The $3.79 average target implies a +63% move from current prices. That is -9% versus the projected 2030 average. Buyers look set to stay in control over this stretch.
The BTMD price prediction for 2032 points to an average of $4.11 (low $2.56, high $7.10) — a potential gain of +77% on today's $2.33. Momentum favours further upside here.
In 2033, BTMD is projected to trade between $2.87 and $8.39, averaging $4.75 — a potential gain of +104% from today's $2.33. That is up +15% on the projected 2032 average. Buyers look set to stay in control over this stretch.
biote Corp.'s 2034 outlook centres on $5.70, within a $3.35 to $10.30 range. That is up +20% on the projected 2033 average. That marks a +145% change versus current levels. Momentum favours further upside here.
By 2035, BTMD could reach as high as $13.09, with a base case around $7.10 and support toward $4.05 — roughly +205% from $2.33. Buyers look set to stay in control over this stretch.
Expect BTMD to range from $4.13 to $16.59 through 2040. The $8.27 average target implies a +255% move from current prices. That is up +16% on the projected 2035 average. Momentum favours further upside here.
The BTMD price prediction for 2050 points to an average of $16.28 (low $7.33, high $36.79) — a potential gain of +599% on today's $2.33. Buyers look set to stay in control over this stretch.
Investing $1,000 in BTMD today (≈ 429.184549 BTMD) could be worth
$6,987.56
+$5,987.56 (+599%) by 2050 · US Dollar
Based on the average projected BTMD price of $16.28 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in BTMDwould be worth at today's price.
$1,000 invested in BTMD on Jul 10, 2025 (≈ 237.529689 BTMD) would be worth
$553.44
-$446.56 (-44.7%) today · 0.55× · US Dollar
Based on a BTMD entry price of $4.21 vs. today's $2.33.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $2.17 | $1,073.73 | +7.4% |
| 1 month ago | $2.27 | $1,026.43 | +2.6% |
| 3 months ago | $1.59 | $1,465.41 | +46.5% |
| 6 months ago | $2.51 | $928.29 | -7.2% |
| 1 year ago | $4.21 | $553.44 | -44.7% |
| All time (5.0y) ago | $9.71 | $239.96 | -76.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our BTMD forecast.
Our base-case forecast reaches $4.70 around 2033.
Implied market cap at $4.70: $142.56M
The multi-year forecast depicts a generally bullish trajectory with rising averages and strong ROIs in the later years. The 2027 average is $3.36 with a 44% ROI, the 2028 average is $3.53, and the 2029 average is $3.74, leading to the 2030 average of $4.19 and a 79.9% ROI. By 2035, the average is projected at $7.10, then $8.27 in 2040 with a 254.9% ROI, and $16.28 in 2050 with a 598.8% ROI.
Across these forecasts, sentiment remains bullish. However, annualized volatility is high, at 80%, underscoring substantial risk and price swings and reminding investors that forecasts are not guarantees. These projections imply meaningful upside potential over the longer horizon, but outcomes will depend on market dynamics and execution of business fundamentals.
Tap a question to reveal the answer.
2030 avg $4.19, min $2.78, max $6.83, ROI 79.9%, sentiment bullish.
The forecast shows bullish sentiment in several years with rising averages and ROIs (e.g., 2027 ROI 44%, 2030 ROI 79.9%, 2040 ROI 254.9%, 2050 ROI 598.8%). In 2026 the avg is $2.33 with neutral sentiment. These are projections, not guarantees.
Yes, according to the forecast, the 2035 max is $13.09 and the 2040 max is $16.59, with the 2050 max $36.79, indicating potential to exceed $10 across the forecast horizon.
Avg $3.36, min $2.52, max $4.80; ROI 44%; sentiment bullish.
Current price $2.33; Market cap $82.84M; Rank 4282.
biote Corp. Community Discussion
0Share your biote Corp. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.